PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia

Cancer Res. 2010 Nov 1;70(21):8792-801. doi: 10.1158/0008-5472.CAN-08-4481. Epub 2010 Sep 21.

Abstract

The PML-RARα oncogene is the central effector of acute promyelocytic leukemia (APL). PML-RARα physically interacts with epigenetic-modifying enzymes including DNA methyltransferases (Dnmt) to suppress critical downstream targets. Here, we show that increased expression of Dnmt3a1 cooperates with PML-RARα in vivo to promote early lethality secondary to myeloid expansion and dysfunction in primary mice. Bone marrow cells from these mice cause leukemogenesis with a shortened latency and a higher penetrance on transplantation into irradiated recipients. Furthermore, leukemic cells overexpressing PML-RARα and Dnmt3a1 display increased methylation at a target promoter compared with PML-RARα or Dnmt3a1 controls. Our findings show a cooperation between the PML-RARα oncogene and the Dnmt3a1 enzyme in vivo and that Dnmt levels can be rate limiting in APL progression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / pathology
  • DNA (Cytosine-5-)-Methyltransferases / genetics*
  • DNA Methylation*
  • DNA Methyltransferase 3A
  • Flow Cytometry
  • Genes, Lethal*
  • Humans
  • Inflammation / etiology
  • Inflammation / pathology
  • Leukemia, Promyelocytic, Acute / etiology*
  • Leukemia, Promyelocytic, Acute / pathology
  • Mice
  • Mice, Transgenic
  • Oncogene Proteins, Fusion / genetics*
  • Promoter Regions, Genetic / genetics
  • Respiratory Burst
  • Survival Rate

Substances

  • DNMT3A protein, human
  • Oncogene Proteins, Fusion
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A